Streetbeat News

Products Services

NNOX

NANO-X IMAGING shares surged as traders discussed analyst comments about the company's integration of AI into its imaging platform. The potential FDA 510(k) approval could expand its clinical applications and improve system utilization.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:18 pm

DJD

SPDG

VZ

Verizon Communications Inc (NYSE:VZ) has partnered with Vay to integrate 5G connectivity into Vay's teledriving electric vehicle fleet. This collaboration aids Vay's entry into the U.S. market. Verizon is focusing on cost-cutting measures following underwhelming quarterly results, including a severance charge and asset discontinuation. Verizon's stock has risen by 34% over the past year, and investors can access it through ETFs like Invesco DJD and SPDR SPDG.

Portfolio Pulse from Anusuya Lahiri

September 24, 2024 | 3:13 pm

TVGN

Tevogen Bio, a biotech company listed on NASDAQ, is making strides in developing T cell therapeutics for infectious diseases and cancers. The company recently met with Congress to discuss its ExacTcell technology as a solution for Long COVID. Tevogen Bio has achieved significant milestones, including positive clinical trial results for its lead product, TVGN 489, and a robust intellectual property portfolio. The company is now publicly traded and included in the Russell 3000 Index.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:13 pm

AIMD

AIMDW

Ainos, Inc. is set to begin a clinical study for VELDONA® in treating Sjogren's syndrome in December 2024 in Taiwan. The study aims to evaluate the drug's effectiveness in improving saliva secretion and dryness symptoms. Previous U.S. Phase 3 data showed significant benefits.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:08 pm

RELL

Richardson Electronics has entered a global distribution agreement with Quantic MWD to expand its portfolio with microwave and millimeter wave products. This partnership aims to enhance product accessibility for various applications, including space, defense, and industrial sectors.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:07 pm

EBS

Los Angeles County reports a doubling of mpox cases, urging vaccinations for high-risk groups. The JYNNEOS vaccine is available at pharmacies and public health clinics. Health officials recommend safe sex practices and testing for symptoms.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:06 pm

INTC

SMCI

Supermicro has expanded its X14 server line with new Intel-based systems optimized for AI, HPC, cloud, and edge workloads. These systems feature next-gen GPU support, 400GbE networking, and direct-to-chip liquid cooling.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:06 pm

AAPL

GOOGL

NVDA

TSM

Taiwan Semiconductor Manufacturing Co (TSM) has secured a $7.5 billion investment for its Arizona expansion, aiming for advanced chip production. The company plans to start mass production with 4nm technology next year and further expand with 3nm and 2nm technology by 2028. TSM's stock has risen 103% in the past year, driven by its role as a key supplier of AI chips to major tech companies.

Portfolio Pulse from Anusuya Lahiri

September 24, 2024 | 3:05 pm

SAVA

Cassava Sciences announced the completion of an interim safety review for its Alzheimer's drug candidate, simufilam, in Phase 3 trials. The review, conducted by an independent board, recommended the trials continue without changes. The trials are fully enrolled with over 1,900 patients, and results are expected by the end of 2024 and mid-2025. Cassava's stock rose by 3.28% following the announcement.

Portfolio Pulse from Vaishali Prayag

September 24, 2024 | 3:04 pm

SLXN

Silexion Therapeutics shares rose following positive results from its Phase 2 trial of LODER for non-resectable locally advanced pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:01 pm